University of California, San Francisco, CA, USA.
Berkeley Therapy Institute, Berkeley, CA, USA.
Subst Abus. 2023 Oct;44(4):337-347. doi: 10.1177/08897077231202836. Epub 2023 Oct 30.
Rates of cannabis use are increasing in the United States, likely as a result of changes in societal attitudes and expanding legalization. Although many patients report wanting to discuss the risks and benefits of cannabis use with their clinical providers, many providers hold conflicting beliefs regarding cannabis use and often do not engage patients in discussion about cannabis. This dilemma is underscored by the limitations imposed on cannabis related research, and lack of empirically based best-practice guidelines for clinicians when addressing cannabis use with patients.
We aimed to briefly summarize clinician and patient attitudes toward cannabis use and review current clinical guidelines and provide suggestions to assist health care providers and clinicians in increasing their comfort and skill in discussing cannabis use with patients.
A narrative review on attitudes toward cannabis use and clinical guidelines was performed to summarize the literature and provide evidence-based recommendations.
Attitudes toward cannabis use have been shaped by personal and political factors and contribute to clinician hesitance in speaking with patients about the topic. Administrative barriers have hindered the development of clearer public health guidelines that might enable the dissemination of evidence-based information on the health effects of cannabis use and might ultimately lead to better health outcomes.
Not discussing cannabis use with patients may be a crucial missed opportunity for harm reduction. In the absence of empirically supported best-practice guidelines, a person-centered approach can facilitate conversations on the harms and benefits of cannabis use.
在美国,大麻的使用频率正在上升,这可能是由于社会态度的变化和不断扩大的合法化。尽管许多患者表示希望与临床医生讨论大麻使用的风险和益处,但许多医生对大麻使用持有矛盾的信念,并且通常不与患者讨论大麻问题。这种困境突出了与大麻相关的研究受到限制,以及缺乏针对临床医生在与患者讨论大麻使用时的循证最佳实践指南。
我们旨在简要总结临床医生和患者对大麻使用的态度,回顾当前的临床指南,并提供建议,以帮助医疗保健提供者和临床医生提高他们与患者讨论大麻使用的舒适度和技能。
对大麻使用的态度和临床指南进行了叙述性综述,以总结文献并提供循证建议。
对大麻使用的态度受到个人和政治因素的影响,导致临床医生在与患者讨论该话题时犹豫不决。行政障碍阻碍了更明确的公共卫生指南的制定,这些指南可能使有关大麻使用对健康影响的循证信息得以传播,并最终导致更好的健康结果。
不与患者讨论大麻使用可能是减少伤害的一个重要错失机会。在缺乏经验支持的最佳实践指南的情况下,以患者为中心的方法可以促进关于大麻使用的危害和益处的对话。